IFNG and neoplasm: Numerous murine studies originally suggested an important role for IFN-γ in tumor immunity: mice with targeted deletion of IFNγ or the Type II IFN receptor have an increased risk of spontaneous and chemically-induced tumors compared to controls [1,3,26,61].